Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma
Br J Haematol
.
2024 Dec;205(6):2523-2526.
doi: 10.1111/bjh.19883.
Epub 2024 Nov 13.
Authors
A Schena
1
2
,
F M Quaglia
1
,
A Parisi
3
,
I Ferrarini
1
,
A Moioli
1
,
E Tagliavini
1
,
A Bernardelli
1
,
C Visco
1
Affiliations
1
Section of Haematology, Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.
2
Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
3
Section of Pathology, Department of Diagnostics and Public Health, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
PMID:
39535342
DOI:
10.1111/bjh.19883
No abstract available
Publication types
Letter